Stuart Turville
Overview
Explore the profile of Stuart Turville including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
949
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurdasani D, Trent M, Ziauddeen H, Mnatzaganian E, Turville S, Chen X, et al.
BMJ Paediatr Open
. 2024 Dec;
8(1).
PMID: 39653515
Background: The cause of acute paediatric hepatitis of unknown aetiology (2022) has not been established despite extensive investigation. Objective: To summarise the evidence for and against a causal role for...
2.
Body A, Lal L, Srihari S, MacIntyre C, Buttery J, Ahern E, et al.
Vaccine
. 2024 Dec;
46():126547.
PMID: 39648104
Background: The COVID-19 pandemic has significantly impacted people with cancer. Initial vaccine studies excluded patients with malignancy. Immunocompromised individuals remain vulnerable to SARS-CoV-2, necessitating detailed understanding of vaccine response. The...
3.
Singer J, Tunbridge M, Shi B, Perkins G, Chai C, Salehi T, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932337
Kidney transplant recipients are at an increased risk of hospitalisation and death from SARS-CoV-2 infection, and standard two-dose vaccination schedules are typically inadequate to generate protective immunity. Gut dysbiosis, which...
4.
Jensen T, Murray T, Grandits G, Jain M, Grund B, Shaw-Saliba K, et al.
Lancet Microbe
. 2024 May;
5(6):e559-e569.
PMID: 38815595
Background: Serial measurement of virological and immunological biomarkers in patients admitted to hospital with COVID-19 can give valuable insight into the pathogenic roles of viral replication and immune dysregulation. We...
5.
Harrison K, Carlos P, Ullrich S, Aggarwal A, Johansen-Leete J, Sasi V, et al.
Chemistry
. 2024 May;
30(44):e202401606.
PMID: 38801240
The development of novel antivirals is crucial not only for managing current COVID-19 infections but for addressing potential future zoonotic outbreaks. SARS-CoV-2 main protease (M) is vital for viral replication...
6.
Bedding M, Franck C, Johansen-Leete J, Aggarwal A, Maxwell J, Patel K, et al.
ACS Chem Biol
. 2023 Dec;
19(1):141-152.
PMID: 38085789
The development of effective antiviral compounds is essential for mitigating the effects of the COVID-19 pandemic. Entry of SARS-CoV-2 virions into host cells is mediated by the interaction between the...
7.
Jensen T, Grandits G, Jain M, Murray T, Grund B, Shaw-Saliba K, et al.
J Infect Dis
. 2023 Nov;
229(3):671-679.
PMID: 37948759
Background: Neutralizing monoclonal antibodies (nmAbs) failed to show clear benefit for hospitalized patients with coronavirus disease 2019 (COVID-19). Dynamics of virologic and immunologic biomarkers remain poorly understood. Methods: Participants enrolled...
8.
Rankin K, Hastak P, Wong A, Sasson S, Beaton B, Yeola A, et al.
EJHaem
. 2023 Aug;
4(3):728-732.
PMID: 37601863
Patients with Waldenström macroglobulinaemia (WM) are at increased risk of severe COVID-19 infection and have poor immune responses to COVID-19 vaccination. This study assessed whether a closely monitored pause in...
9.
Angelovich T, Cochrane C, Zhou J, Tumpach C, Byrnes S, Jamal Eddine J, et al.
Ann Neurol
. 2023 Jul;
94(4):798-802.
PMID: 37493435
Here, we provide the first regional analysis of intact and defective HIV reservoirs within the brain. Brain tissue from both viremic and virally suppressed people with HIV (PWH) harbored HIV...
10.
Bowden-Reid E, Ledger S, Zhang Y, Di Giallonardo F, Aggarwal A, Stella A, et al.
Antiviral Res
. 2023 Jul;
217:105677.
PMID: 37478918
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a respiratory virus that causes COVID-19 disease, with an estimated global mortality of approximately 2%. While global response strategies, which are predominantly...